Ftse Mib
36.079,72
0,06%
DAX
21.254,27
1,01%
S&P 500
0,00
0,00%
NASDAQ
20.009,34
1,28%
Bitcoin
102.748,38
-0,86%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ImmunoPrecise Antibodies Ltd (IPA) ImmunoPrecise Antibodies Ltd (IPA) Notizie

ImmunoPrecise Antibodies Ltd

IPA
0,5849
0,0919 (18,64%)
23 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/1/202520:19BWIPA (ImmunoPrecise Antibodies), pionnier des thérapies GLP-1..
22/1/202516:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/1/202513:02BWIPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1..
18/1/202503:25BWImmunoPrecise Antibodies redéfinit sa stratégie de pipeline..
17/1/202517:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202514:01BWImmunoPrecise Antibodies Realigns Pipeline Strategy,..
03/1/202516:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/1/202513:44BWL'IPA annonce la démission de sa directrice financière
01/1/202501:56BWIPA Announces Resignation of Chief Financial Officer
23/12/202418:02BWImmunoPrecise Antibodies (IPA) démontre une solide confiance..
23/12/202415:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/12/202414:30BWImmunoPrecise Antibodies (IPA) Demonstrates Strong Market..
19/12/202418:56BWPrésentation de l'IPA à la Microcap Conference 2025
19/12/202414:00BWIPA to Present at The Microcap Conference 2025
11/12/202412:34BWImmunoPrecise Antibodies (IPA) publie ses résultats..
10/12/202414:37EDGAR2Form 20-F/A - Annual and transition report of foreign..
10/12/202414:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202414:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202414:30BWImmunoPrecise Antibodies (IPA) Reports Financial Results and..
05/12/202412:23BWL'IPA participera à la prochaine conférence de découverte en..
04/12/202414:00BWIPA to Present at The Benchmark Company’s Upcoming Discovery..
04/12/202405:08BWL'IPA publiera ses résultats financiers et les faits..
03/12/202414:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/12/202414:30BWIPA to Report Financial Results and Recent Business..
14/11/202421:13BWUne percée commerciale de 20 milliards de dollars : l'IPA..
13/11/202415:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202415:00BW$20 Billion Market Breakthrough: IPA Pioneers High-Impact..
05/11/202407:53BWImmunoPrecise annonce son TECHDAY, un événement dédié à..
04/11/202414:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202414:01BWImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics..
29/10/202402:59BWImmunoPrecise soutient la recherche antivieillissement dans..
28/10/202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/10/202412:30BWImmunoPrecise Advances Anti-Aging Research with Mayo Clinic..
23/10/202412:11BWImmunoPrecise Antibodies participera à l'AI Driven Drug..
21/10/202415:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/10/202415:00BWImmunoPrecise Antibodies to Participate at the AI Driven..
11/10/202421:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/10/202401:50BWImmunoPrecise Antibodies célèbre le prix Nobel de chimie et..
10/10/202415:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202414:10BWImmunoPrecise Antibodies Celebrates Nobel Prize in..
02/10/202420:06BWUne filiale d'ImmunoPrecise signe un accord de transfert de..
02/10/202414:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202414:00BWImmunoPrecise Subsidiary Signs Material Transfer Agreement..
26/9/202415:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202415:00BWImmunoPrecise Antibodies Advances Therapeutic Innovation..
23/9/202420:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/9/202404:13BWImmunoPrecise Antibodies (IPA) publie ses résultats..
16/9/202422:01EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16/9/202415:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202415:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 0,7201 Min: 0,6086 Max: 0,9244
Chiusura: 0,493

La tua Cronologia

NASDAQ
IPA
ImmunoPrecise Antibodies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network